Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors
Tài liệu tham khảo
Filipits, 2004, Mechanisms of cancer: multidrug resistance, Drug Discov Today Dis Mech, 1, 229, 10.1016/j.ddmec.2004.10.001
Krishna, 2001, Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators, Curr Med Chem Anticancer Agents, 1, 163, 10.2174/1568011013354705
Zastre, 2004, Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-polycaprolactone amphiphilic diblock copolymers, Pharm Res, 21, 1489, 10.1023/B:PHAM.0000036925.45002.a2
Mamot, 2003, Liposome-based approaches to overcome anticancer drug resistance, Drug Resist Updat, 6, 271, 10.1016/S1368-7646(03)00082-7
Kabanov, 2002, Pluronic((R)) block copolymers for overcoming drug resistance in cancer, Adv Drug Deliv Rev, 54, 759, 10.1016/S0169-409X(02)00047-9
Alakhov, 1999, Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials, Colloids Surf B Biointerfaces, 16, 113, 10.1016/S0927-7765(99)00064-8
Lee, 2005, Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor, J Control Release, 103, 405, 10.1016/j.jconrel.2004.12.018
Wang, 2007, Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines, Int J Pharm, 337, 63, 10.1016/j.ijpharm.2006.12.033
Wang, 2008, Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles, Arch Pharm Res, 31, 530, 10.1007/s12272-001-1189-2
Kim, 2001, Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers, Biomaterials, 22, 1697, 10.1016/S0142-9612(00)00292-1
Zastre, 2002, Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers, Eur J Pharm Biopharm, 54, 299, 10.1016/S0939-6411(02)00119-4
Ha, 1999, Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (pluronic)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - I. Preparation and characterization, J Control Release, 62, 381, 10.1016/S0168-3659(99)00167-4
Kim, 2000, Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - II. Thermo-responsive drug release behaviors, J Control Release, 65, 345, 10.1016/S0168-3659(99)00207-2
Ge, 2002, Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon- caprolactone)-poly(ethylene oxide)-poly(epsilon- caprolactone) amphiphilic triblock copolymer micelles, J Pharm Sci, 91, 1463, 10.1002/jps.10143
Shin, 1998, Methoxy poly(ethylene glycol)/[epsilon]-caprolactone amphiphilic block copolymeric micelle containing indomethacin.: I. Preparation and characterization, J Control Release, 51, 1, 10.1016/S0168-3659(97)00164-8
Han, 2008, Establishment and biological characterization of paclitaxel-resistant cell line of human ovarian carcinoma, Fudan Univ J Med Sci, 35, 171
Miller, 1997, Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption, Bioconjug Chem, 8, 649, 10.1021/bc970118d
Garewal, 1986, ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects, J Natl Cancer Inst, 77, 1039
Salvioli, 2000, Opposite role of changes in mitochondrial membrane potential in different apoptotic processes, FEBS Lett, 469, 186, 10.1016/S0014-5793(00)01266-7
Marchetti, 1996, Mitochondrial permeability transition is a central coordinating event of apoptosis, J Exp Med, 184, 1155, 10.1084/jem.184.3.1155
Simon, 2005, Low dose (-)deprenyl is cytoprotective: it maintains mitochondrial membrane potential and eliminates oxygen radicals, Life Sci, 78, 225, 10.1016/j.lfs.2005.04.078
de Laat, 1977, Microviscosity modulation during the cell cycle of neuroblastoma cells, Proc Natl Acad Sci U S A, 74, 4458, 10.1073/pnas.74.10.4458
Batrakova, 2001, Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization, J Pharmacol Exp Ther, 299, 483
Batrakova, 2003, Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85, Pharm Res, 20, 1581, 10.1023/A:1026179132599
Kim, 2001, In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy, J Control Release, 72, 191, 10.1016/S0168-3659(01)00275-9
Yoo, 2004, Folate receptor targeted biodegradable polymeric doxorubicin micelles, J Control Release, 96, 273, 10.1016/j.jconrel.2004.02.003
Wang, 2003, Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway, World J Gastroenterol, 9, 1904, 10.3748/wjg.v9.i9.1904
Rapoport, 2003, Drug delivery in polymeric micelles: from in vitro to in vivo, J Control Release, 91, 85, 10.1016/S0168-3659(03)00218-9
Lee, 1994, Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen, Mol Pharmacol, 46, 627
Wang, 2008, Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor, Acta Pharmaceutica Sinica, 43, 640
Gao, 2005, Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound, J Control Release, 102, 203, 10.1016/j.jconrel.2004.09.021
Kabanov, 2002, Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery, J Control Release, 82, 189, 10.1016/S0168-3659(02)00009-3
Batrakova, 1999, Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells, Pharm Res, 16, 1373, 10.1023/A:1018942823676
Wang, 2008, Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P105/poly(caprolactone) copolymers, Pharmazie, 63, 446
Kwon, 1996, Polymeric micelles as new drug carriers, Adv Drug Deliv Rev, 21, 107, 10.1016/S0169-409X(96)00401-2
